Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
110815283 | 11081528 | 3 | F | 20160829 | 20150501 | 20160829 | EXP | NL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-025839 | BRISTOL MYERS SQUIBB | 0.00 | F | Y | 0.00000 | 20160829 | CN | NL | NL |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
110815283 | 11081528 | 1 | I | CISPLATIN. | CISPLATIN | 1 | Intravenous (not otherwise specified) | UNK | U | U | 0 | ||||||||
110815283 | 11081528 | 2 | PS | ETOPOSIDE. | ETOPOSIDE | 1 | Intravenous (not otherwise specified) | 2 COURSES WITH 3 WEEKS IN BETWEEN | U | U | 18768 | ||||||||
110815283 | 11081528 | 3 | I | DOXORUBICIN | DOXORUBICIN | 1 | Intravenous (not otherwise specified) | UNK MG/ML, UNK | U | U | 0 | INJECTION | |||||||
110815283 | 11081528 | 4 | I | IFOSFAMIDE. | IFOSFAMIDE | 1 | Intravenous (not otherwise specified) | 2 COURSES WITH 3 WEEKS IN BETWEEN | U | U | 0 | INJECTION | |||||||
110815283 | 11081528 | 5 | I | VINCRISTINE | VINCRISTINE | 1 | Intravenous (not otherwise specified) | 2 COURSES WITH 3 WEEKS IN BETWEEN | U | U | 0 | INJECTION | |||||||
110815283 | 11081528 | 6 | C | FRAXIPARINE /01437701/ | NADROPARIN CALCIUM | 1 | Intravenous (not otherwise specified) | 2850 IU/ML, QD | U | U | 0 | 2850 | DF | INJECTION | QD | ||||
110815283 | 11081528 | 7 | C | MESNA. | MESNA | 1 | Intravenous (not otherwise specified) | 150 MG, QD | U | U | 0 | 150 | MG | INJECTION | QD | ||||
110815283 | 11081528 | 8 | C | ONDANSETRON | ONDANSETRON | 1 | Intravenous (not otherwise specified) | 8 MG, BID | U | U | 0 | 8 | MG | INJECTION | BID | ||||
110815283 | 11081528 | 9 | C | LYRICA | PREGABALIN | 1 | Unknown | 75 MG, BID | U | U | 0 | 75 | MG | CAPSULE | BID | ||||
110815283 | 11081528 | 10 | C | EMEND | APREPITANT | 1 | Oral | 80 MG QD PLUS A SINGLE DOSE OF 125MG | U | U | 0 | 80 | MG | CAPSULE | QD | ||||
110815283 | 11081528 | 11 | C | EMEND | APREPITANT | 1 | Oral | 80 MG QD PLUS A SINGLE DOSE OF 125MG | U | U | 0 | 125 | MG | CAPSULE | QD | ||||
110815283 | 11081528 | 12 | C | FENTANYL. | FENTANYL | 1 | Transdermal | 75 MCG/HR ONCE EVERY 3 DAYS | U | U | 0 | 75 | UG | PATCH | |||||
110815283 | 11081528 | 13 | C | PARACETAMOL | ACETAMINOPHEN | 1 | Unknown | 1000 MG, TID | U | U | 0 | 1000 | MG | SUPPOSITORY | TID | ||||
110815283 | 11081528 | 14 | C | CLONIDINE. | CLONIDINE | 1 | Unknown | 75 ?G, BID | U | U | 0 | 75 | UG | BID | |||||
110815283 | 11081528 | 15 | C | LORAZEPAM. | LORAZEPAM | 1 | Unknown | 1 MG, ONCE A DAY AS NEEDED | U | U | 0 | 1 | MG | TABLET | QD | ||||
110815283 | 11081528 | 16 | C | LACTULOSE. | LACTULOSE | 1 | Oral | 15 ML, BID | U | U | 0 | 15 | ML | SYRUP | BID | ||||
110815283 | 11081528 | 17 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | UNK, PRN | U | U | 0 | ||||||||
110815283 | 11081528 | 18 | C | COLECALCIFEROL | CHOLECALCIFEROL | 1 | Unknown | 10 IU/ML, QD | U | U | 0 | 10 | DF | DROP | QD | ||||
110815283 | 11081528 | 19 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Intravenous (not otherwise specified) | 10 MG, QD | U | U | 0 | 10 | MG | INJECTION | QD | ||||
110815283 | 11081528 | 20 | C | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Unknown | 2300 MG, ONE TIME DOSE | U | U | 0 | 2300 | MG | ||||||
110815283 | 11081528 | 21 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Unknown | 10 MG, QD | U | U | 0 | 10 | MG | TABLET | QD | ||||
110815283 | 11081528 | 22 | SS | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | Oral | 8 MG, BID | U | U | 0 | 8 | MG | TABLET | BID | ||||
110815283 | 11081528 | 23 | C | ABSTRAL | FENTANYL CITRATE | 1 | Sublingual | 200 ?G, PRN | U | U | 0 | 200 | UG | TABLET |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
110815283 | 11081528 | 1 | Ewing's sarcoma |
110815283 | 11081528 | 2 | Ewing's sarcoma |
110815283 | 11081528 | 3 | Ewing's sarcoma |
110815283 | 11081528 | 4 | Ewing's sarcoma |
110815283 | 11081528 | 5 | Ewing's sarcoma |
110815283 | 11081528 | 6 | Product used for unknown indication |
110815283 | 11081528 | 7 | Product used for unknown indication |
110815283 | 11081528 | 8 | Product used for unknown indication |
110815283 | 11081528 | 9 | Product used for unknown indication |
110815283 | 11081528 | 10 | Product used for unknown indication |
110815283 | 11081528 | 12 | Product used for unknown indication |
110815283 | 11081528 | 13 | Product used for unknown indication |
110815283 | 11081528 | 14 | Product used for unknown indication |
110815283 | 11081528 | 15 | Product used for unknown indication |
110815283 | 11081528 | 16 | Product used for unknown indication |
110815283 | 11081528 | 17 | Product used for unknown indication |
110815283 | 11081528 | 18 | Product used for unknown indication |
110815283 | 11081528 | 19 | Product used for unknown indication |
110815283 | 11081528 | 20 | Product used for unknown indication |
110815283 | 11081528 | 21 | Product used for unknown indication |
110815283 | 11081528 | 22 | Product used for unknown indication |
110815283 | 11081528 | 23 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
110815283 | 11081528 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
110815283 | 11081528 | Drug interaction | |
110815283 | 11081528 | Malnutrition | |
110815283 | 11081528 | Maternal exposure during pregnancy | |
110815283 | 11081528 | Off label use | |
110815283 | 11081528 | Sepsis | |
110815283 | 11081528 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
110815283 | 11081528 | 1 | 20150120 | 0 | ||
110815283 | 11081528 | 2 | 20150220 | 0 | ||
110815283 | 11081528 | 3 | 20150220 | 0 | ||
110815283 | 11081528 | 4 | 20150220 | 0 | ||
110815283 | 11081528 | 5 | 20150220 | 0 |